These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27759599)

  • 1. Aortic and Hepatic Contrast Enhancement During Hepatic-Arterial and Portal Venous Phase Computed Tomography Scanning: Multivariate Linear Regression Analysis Using Age, Sex, Total Body Weight, Height, and Cardiac Output.
    Masuda T; Nakaura T; Funama Y; Higaki T; Kiguchi M; Imada N; Sato T; Awai K
    J Comput Assist Tomogr; 2017; 41(2):309-314. PubMed ID: 27759599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of the Correlation between Patient Characteristics and Contrast Enhancement during Hepatic Dynamic CT Scan: Comparison by the Sex].
    Ikenaga H; Masuda T; Ishikawa T; Tani T; Moriwake R; Yao D
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2024 Feb; 80(2):199-206. PubMed ID: 38104981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-detector row helical CT of the liver: quantitative assessment of iodine concentration of intravenous contrast material on multiphasic CT--a prospective randomized study.
    Tsurusaki M; Sugimoto K; Fujii M; Sugimura K
    Radiat Med; 2004; 22(4):239-45. PubMed ID: 15468944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body size indexes for optimizing iodine dose for aortic and hepatic enhancement at multidetector CT: comparison of total body weight, lean body weight, and blood volume.
    Kondo H; Kanematsu M; Goshima S; Tomita Y; Kim MJ; Moriyama N; Onozuka M; Shiratori Y; Bae KT
    Radiology; 2010 Jan; 254(1):163-9. PubMed ID: 20019137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
    Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
    Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Patient Characteristics on Vessel Enhancement in Pediatric Chest Computed Tomography Angiography.
    Masuda T; Nakaura T; Funama Y; Sato T; Nitta T; Higaki T; Baba Y; Matsumoto Y; Imada N; Awai K
    Can Assoc Radiol J; 2019 May; 70(2):181-185. PubMed ID: 30600124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging.
    Sultana S; Awai K; Nakayama Y; Nakaura T; Liu D; Hatemura M; Funama Y; Morishita S; Yamashita Y
    Radiology; 2007 Apr; 243(1):140-7. PubMed ID: 17329690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDCT of the pancreas: optimizing scanning delay with a bolus-tracking technique for pancreatic, peripancreatic vascular, and hepatic contrast enhancement.
    Kondo H; Kanematsu M; Goshima S; Miyoshi T; Shiratori Y; Onozuka M; Moriyama N; Bae KT
    AJR Am J Roentgenol; 2007 Mar; 188(3):751-6. PubMed ID: 17312064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreas: patient body weight tailored contrast material injection protocol versus fixed dose protocol at dynamic CT.
    Yanaga Y; Awai K; Nakayama Y; Nakaura T; Tamura Y; Hatemura M; Yamashita Y
    Radiology; 2007 Nov; 245(2):475-82. PubMed ID: 17890356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Patient Factors on Portal Vein and Hepatic Contrast Enhancement at Computed Tomography Scan With Protocol Combining Fixed Injection Duration and Patients' Body Weight Tailored Dose of Contrast Material.
    Ye H
    Cureus; 2022 Sep; 14(9):e29283. PubMed ID: 36147863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An optimal contrast dose indicator for the determination of hepatic enhancement in abdominal multidetector computed tomography: comparison of patient attenuation indicator with total body weight and body mass index.
    Li J; Udayasankar UK; Tang X; Carew J; Toth TL; Small WC
    J Comput Assist Tomogr; 2010; 34(6):874-8. PubMed ID: 21084903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic and hepatic contrast enhancement with abdominal 64-MDCT in pediatric patients: effect of body weight and iodine dose.
    Bae KT; Shah AJ; Shang SS; Wang JH; Chang S; Kanematsu M; Hildebolt CF
    AJR Am J Roentgenol; 2008 Nov; 191(5):1589-94. PubMed ID: 18941106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity.
    Brook OR; Gourtsoyianni S; Brook A; Siewert B; Kent T; Raptopoulos V
    Radiology; 2013 Oct; 269(1):139-48. PubMed ID: 23674791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic and hepatic enhancement at multidetector CT: evaluation of optimal iodine dose determined by lean body weight.
    Kondo H; Kanematsu M; Goshima S; Watanabe H; Onozuka M; Moriyama N; Bae KT
    Eur J Radiol; 2011 Dec; 80(3):e273-7. PubMed ID: 21195572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining contrast medium dose and rate on basis of lean body weight: does this strategy improve patient-to-patient uniformity of hepatic enhancement during multi-detector row CT?
    Ho LM; Nelson RC; Delong DM
    Radiology; 2007 May; 243(2):431-7. PubMed ID: 17456869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Optimal Body Size Index with Which to Determine Iodine Dose for Hepatic Dynamic CT: A Prospective Multicenter Study.
    Awai K; Kanematsu M; Kim T; Ichikawa T; Nakamura Y; Nakamoto A; Yoshioka K; Mochizuki T; Matsunaga N; Yamashita Y
    Radiology; 2016 Mar; 278(3):773-81. PubMed ID: 26356063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of contrast injection protocols with dose adjusted to the estimated lean patient body weight on aortic enhancement at CT angiography.
    Yanaga Y; Awai K; Nakaura T; Oda S; Funama Y; Bae KT; Yamashita Y
    AJR Am J Roentgenol; 2009 Apr; 192(4):1071-8. PubMed ID: 19304716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of contrast material for spiral CT of the abdomen: comparison of hepatic enhancement and vascular attenuation for three different contrast media at two different delay times.
    Herts BR; Paushter DM; Einstein DM; Zepp R; Friedman RA; Obuchowski N
    AJR Am J Roentgenol; 1995 Feb; 164(2):327-31. PubMed ID: 7839963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of the hepatic arterial phase during contrast-enhanced computed tomography of the liver: assessment of normal values in 25 volunteers.
    Bader TR; Prokesch RW; Grabenwöger F
    Invest Radiol; 2000 Aug; 35(8):486-92. PubMed ID: 10946976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 2 contrast materials with different iodine concentrations in 3-dimensional computed tomography angiography of the hepatic artery at multi-detector-row computed tomography: a randomized study.
    Suzuki H; Shibamoto Y; Oshima H; Takeuchi M; Ito M; Hara M
    J Comput Assist Tomogr; 2007; 31(6):840-5. PubMed ID: 18043345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.